The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Windtree Therapeutics and Eleison announced positive results of the feasibility study using Windtree's proprietary Aerosol Delivery System ...
read more
Armas Pharmaceuticals and Micro Labs USA have announced the forming of a strategic collaboration to bring select multisource injectable products to ...
read more
Eli Lilly and Company's Insulin Lispro Injection is now available for order in pharmacies for people who use Lilly's rapid-acting insulin and need a ...
read more
UCB announced the FDA has approved NAYZILAM® nasal spray CIV, a benzodiazepine indicated for the acute treatment of intermittent, stereotypic episodes...
read more
Stryker announced the Premarket Approval (PMA) of the Neuroform Atlas Stent System by the FDA.
read more
Intec Pharma has announced the European Patent Office has granted the Company European Patent No. 2997953 titled, "DELIVERY DEVICE FOR ORAL INTAKE OF ...
read more
The FDA approved Fragmin injection, for subcutaneous use, to reduce the recurrence of symptomatic venous thromboembolism in pediatric patients one ...
read more
RegeneRx announced the first patient has been enrolled in ARISE-3, a phase 3 clinical trial sponsored by ReGenTree, a U.S. joint venture between ...
read more
NanoViricides has completed manufacture of the drug for the upcoming GLP Safety/Toxicology study of its lead candidate in several kilogram quantities.
read more
Par Pharmaceutical is voluntarily recalling one lot of Mycophenolate Mofetil for Injection, USP to the hospital and retail pharmacy level.
read more
Regeneron Pharmaceuticals and Sanofi announced that the European Commission approved a new indication for Dupixent® (dupilumab) in asthma.
read more
United Therapeutics and DEKA announced receipt of 510(k) clearance by the FDA for the Unity Subcutaneous Delivery System for Remodulin Injection.
read more
Sagent Pharmaceuticals announced the voluntary nationwide recall of one lot of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL).
read more
Heron Therapeutics announced it received a CRL from the FDA on April 30, 2019 regarding its New Drug Application for HTX-011 for the management of ...
read more
AmEx Pharmacy is voluntarily recalling one Lot of Bevacizumab 1.25mg/0.05mL 31G Injectable to the consumer/user level.
read more